Literature DB >> 24934135

Epilepsy: Chemical-genetic seizure silencing--unlocking the potential.

Heather Wood.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24934135     DOI： 10.1038/nrneurol.2014.104

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  3 in total

1.  Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.

Authors:  Robert C Wykes; Joost H Heeroma; Laura Mantoan; Kaiyu Zheng; Douglas C MacDonald; Karl Deisseroth; Kevan S Hashemi; Matthew C Walker; Stephanie Schorge; Dimitri M Kullmann
Journal:  Sci Transl Med       Date:  2012-11-12       Impact factor: 17.956

2.  Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury.

Authors:  Jeanne T Paz; Thomas J Davidson; Eric S Frechette; Bruno Delord; Isabel Parada; Kathy Peng; Karl Deisseroth; John R Huguenard
Journal:  Nat Neurosci       Date:  2012-11-07       Impact factor: 24.884

3.  Chemical-genetic attenuation of focal neocortical seizures.

Authors:  Dennis Kätzel; Elizabeth Nicholson; Stephanie Schorge; Matthew C Walker; Dimitri M Kullmann
Journal:  Nat Commun       Date:  2014-05-27       Impact factor: 14.919
  3 in total
  1 in total

1.  Adiabatic dynamic causal modelling.

Authors:  Amirhossein Jafarian; Peter Zeidman; Rob C Wykes; Matthew Walker; Karl J Friston
Journal:  Neuroimage       Date:  2021-06-08       Impact factor: 6.556
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.